- Home
- CUE vs MODV Comparison
CUE vs MODV Comparison
Compare CUE & MODV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CUE
- MODV
- Stock Information
- Founded
- CUE 2014
- MODV 1996
- Country
- CUE United States
- MODV United States
- Employees
- CUE N/A
- MODV N/A
- Industry
- CUE Biotechnology: Pharmaceutical Preparations
- MODV Transportation Services
- Sector
- CUE Health Care
- MODV Consumer Discretionary
- Exchange
- CUE Nasdaq
- MODV Nasdaq
- Market Cap
- CUE 48.0M
- MODV 48.9M
- IPO Year
- CUE 2018
- MODV N/A
- Fundamental
- Price
- CUE $0.74
- MODV $3.32
- Analyst Decision
- CUE Strong Buy
- MODV Buy
- Analyst Count
- CUE 3
- MODV 4
- Target Price
- CUE $3.00
- MODV $9.17
- AVG Volume (30 Days)
- CUE 323.3K
- MODV 1.1M
- Earning Date
- CUE 08-13-2025
- MODV 08-06-2025
- Dividend Yield
- CUE N/A
- MODV N/A
- EPS Growth
- CUE N/A
- MODV N/A
- EPS
- CUE N/A
- MODV N/A
- Revenue
- CUE $7,991,000.00
- MODV $2,753,789,000.00
- Revenue This Year
- CUE N/A
- MODV N/A
- Revenue Next Year
- CUE $23.84
- MODV $4.90
- P/E Ratio
- CUE N/A
- MODV N/A
- Revenue Growth
- CUE 13.83
- MODV N/A
- 52 Week Low
- CUE $0.45
- MODV $0.87
- 52 Week High
- CUE $1.99
- MODV $32.82
- Technical
- Relative Strength Index (RSI)
- CUE 51.10
- MODV 59.45
- Support Level
- CUE $0.65
- MODV $3.01
- Resistance Level
- CUE $0.83
- MODV $3.74
- Average True Range (ATR)
- CUE 0.07
- MODV 0.43
- MACD
- CUE 0.01
- MODV -0.01
- Stochastic Oscillator
- CUE 30.43
- MODV 60.58
About CUE Cue Biopharma Inc.
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.
About MODV ModivCare Inc.
ModivCare Inc is a technology-enabled healthcare services company that provides a suite of integrated supportive care solutions for payors and their members. Its solutions address the social determinants of health (SDoH) by connecting members to essential care services. Its various service offerings include non-emergency medical transportation, personal care, virtual and remote monitoring, consumer health engagement, and integrated supportive care. The company's reportable segments are NEMT, PCS, Monitoring, and Corporate and Other. A majority of its revenue is generated from the NEMT segment, which provides non-emergency medical transportation services.